Bluebird Bio (BLUE) PT Lifted to $119 at Piper Jaffray
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
bluebird bio (BLUE) Misses Q4 EPS by 10c
February 25, 2015 4:09 PM ESTbluebird bio (NASDAQ: BLUE) reported Q4 EPS of ($0.67), $0.10 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $6.3 million versus the consensus estimate of $6.2 million.
For earnings history and earnings-related data on bluebird bio (BLUE) click here.
... More